Novid Rassouli Upgraded (X) to Buy and Increased Target to $60 on, Feb 27th, 2017
Novid has made no other calls on X in the last 4 months.
There are 7 other peers that have a rating on X. Out of the 7 peers that are also analyzing X, 3 agree with Novid's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Alexander Hacking of "Citigroup" Downgraded from Strong Buy to Hold on, Thursday, January 19th, 2017
- Curt Woodworth of "Credit Suisse" Downgraded from Buy to Hold and Increased Target to $30 on, Thursday, January 12th, 2017
- Matthew Korn of "Barclays" Maintained at Hold with Increased Target to $27 on, Wednesday, November 23rd, 2016
These are the ratings of the 4 analyists that currently disagree with Novid
- David Coleman of "Argus Research" Upgraded from Hold to Strong Buy on, Tuesday, February 7th, 2017
- Timna Tanners of "B of A Securities" Upgraded from Hold to Strong Buy on, Thursday, February 2nd, 2017
- Jorge Beristain of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $40 on, Monday, December 5th, 2016
- Carlos De Alba of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $46 on, Monday, November 14th, 2016
Like: 👍
on: Tue, Feb 07th 2017
by: WOPRAI
on: Thu, Feb 02nd 2017
by: WOPRAI
on: Thu, Jan 19th 2017
by: WOPRAI
on: Thu, Jan 12th 2017
by: WOPRAI
Curt Woodworth Downgraded (X) to Hold and Increased Target to $30 on, Jan 12th, 2017
on: Thu, Apr 28th 2016
by: WOPRAI
on: Tue, Apr 19th 2016
by: WOPRAI
Matthew Korn Maintained (X) at Hold with Increased Target to $15 on, Apr 19th, 2016
on: Tue, Nov 29th 2016
by: WOPRAI
on: Fri, Apr 08th 2016
by: WOPRAI
Andreas Bokkenheuser Downgraded (X) to Strong Sell on, Apr 8th, 2016
on: Mon, Dec 05th 2016
by: WOPRAI
Jorge Beristain Maintained (X) at Strong Buy with Increased Target to $40 on, Dec 5th, 2016
on: Wed, Nov 23rd 2016
by: WOPRAI
Matthew Korn Maintained (X) at Hold with Increased Target to $27 on, Nov 23rd, 2016
on: Fri, Feb 03rd 2017
by: WOPRAI
on: Thu, Jan 30th 2014
by: WOPRAI
Aldo Mazzaferro Upgraded (X) to Buy and Increased Target to $30 on, Jan 30th, 2014
